| Stereochemistry | ABSOLUTE |
| Molecular Formula | C7H8FN3O4 |
| Molecular Weight | 217.1545 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
N[C@@H](CN1C=C(F)C(=O)NC1=O)C(O)=O
InChI
InChIKey=DBWPFHJYSTVBCZ-BYPYZUCNSA-N
InChI=1S/C7H8FN3O4/c8-3-1-11(2-4(9)6(13)14)7(15)10-5(3)12/h1,4H,2,9H2,(H,13,14)(H,10,12,15)/t4-/m0/s1
| Molecular Formula | C7H8FN3O4 |
| Molecular Weight | 217.1545 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
| 14.7 nM [Ki] | |||
| 25.1 nM [Ki] | |||
| 380.0 nM [EC50] | |||
| 463.0 nM [EC50] |